Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.

ABSTRACT:

SUBMITTER: Goel G 

PROVIDER: S-EPMC5676538 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature